Stock Market & Financial Investment News

News Breaks October 12, 2012 07:16 EDT EXAS Exact Sciences downgraded to Neutral from Outperform at Wedbush Wedbush downgraded Exact Sciences citing valuation and high expectations for next week's data presentation at AACR meeting. Price target is $11. News For EXAS From The Last 14 Days Check below for free stories on EXAS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 18, 2013 09:05 EDT EXAS Exact Sciences 5.5M share Spot Secondary priced at $12.35 Subscribe for More Information June 17, 2013 19:02 EDT EXAS On The Fly: After Hours Movers HIGHER: Korn/Ferry (KFY), up 2.7% after reporting better than expected fourth quarter earnings... Rambus (RMBS), up 3.2% after the company narrowed its second quarter revenue view. LOWER: GenMark (GNMK), down 4.7% after lower its full-year revenue view to $30M from $35M... Also lower following the announcement of stock offerings were Ship Finance (SFL), down 5.1%, New Mountain Finance (NMFC), down 3.3%, and Exact Sciences (EXAS), down 3.1%. 16:06 EDT EXAS Exact Sciences proposes public offering of undisclosed amount of common stock Jefferies LLC and Robert W. Baird & Co. Incorporated are acting as joint book-running managers for the proposed offering. June 10, 2013 07:48 EDT EXAS Exact Sciences says Cologuard premarket approval application to FDA completed Exact Sciences announced that it has submitted to the U.S. Food and Drug Administration the final module of the premarket approval application for Cologuard, the company’s stool DNA colorectal cancer screening test. The final module, which is comprised of data from the company’s DeeP-C clinical trial, completes the company’s PMA application for the product. The final module was submitted to the FDA on Friday, June 7. The company said it will submit the DeeP-C study’s pivotal data set for publication in a peer-reviewed journal, presentation at a major medical meeting or both. The company also announced the expansion of Maneesh K. Arora’s chief operating officer responsibilities to include the oversight of U.S. sales and marketing. The company is in the process of building out its commercial leadership team and is also conducting a search for a senior financial officer, it said. Sign up for a free trial to see the rest of the stories you've been missing.